Calprotectin in inflammatory bowel disease.

导出 OA

翻译打印收藏纠错

作者： Fatemeh,Khaki-Khatibi ^[1] ; Durdi,Qujeq ^[2] ; Mehrdad,Kashifard ^[3] ; Soheila,Moein ^[4] ; Mahmood,Maniati ^[5] ; Mostafa,Vaghari-Tabari ^[6]

作者单位： Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ^[1] Cellular and Molecular Biology Research Center (CMBRC), Health Research Institute, Babol University of Medical Sciences, Babol, Iran; Department of Clinical Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran. ^[2] Department of Internal Medicine, Gastroenterology Division, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran. ^[3] Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. ^[4] English Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. ^[5] Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: vagharim@tbzmed.ac.ir. ^[6]

关键词 Endoscopic activity Fecal calprotectin IBD IBD non-invasive management

主题词结肠炎, 溃疡性(Colitis, Ulcerative);结肠镜检查(Colonoscopy);Crohn病(Crohn Disease);粪便(Feces);人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);白细胞L1抗原复合物(Leukocyte L1 Antigen Complex)

DOI 10.1016/j.cca.2020.08.025

PMID 32818491

发布时间 2023-03-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交